X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA GLENMARK PHARMA SHASUN PHARMA/
GLENMARK PHARMA
 
P/E (TTM) x 123.9 14.3 867.9% View Chart
P/BV x 8.5 3.8 226.3% View Chart
Dividend Yield % 0.2 0.3 72.8%  

Financials

 SHASUN PHARMA   GLENMARK PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
GLENMARK PHARMA
Mar-17
SHASUN PHARMA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs94993 9.5%   
Low Rs46729 6.3%   
Sales per share (Unadj.) Rs214.2325.5 65.8%  
Earnings per share (Unadj.) Rs5.339.3 13.6%  
Cash flow per share (Unadj.) Rs15.848.7 32.5%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %1.40.2 616.0%  
Book value per share (Unadj.) Rs53.3159.2 33.5%  
Shares outstanding (eoy) m56.62282.17 20.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.32.6 12.3%   
Avg P/E ratio x13.121.9 59.8%  
P/CF ratio (eoy) x4.417.7 25.0%  
Price / Book Value ratio x1.35.4 24.2%  
Dividend payout %18.75.1 368.2%   
Avg Mkt Cap Rs m3,958242,991 1.6%   
No. of employees `000NA13.0 0.0%   
Total wages/salary Rs m2,16416,408 13.2%   
Avg. sales/employee Rs ThNM7,083.9-  
Avg. wages/employee Rs ThNM1,265.4-  
Avg. net profit/employee Rs ThNM855.1-  
INCOME DATA
Net Sales Rs m12,12791,857 13.2%  
Other income Rs m229374 61.4%   
Total revenues Rs m12,35692,230 13.4%   
Gross profit Rs m1,00920,367 5.0%  
Depreciation Rs m5942,644 22.5%   
Interest Rs m4152,373 17.5%   
Profit before tax Rs m23015,724 1.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m-733,827 -1.9%   
Profit after tax Rs m30211,088 2.7%  
Gross profit margin %8.322.2 37.5%  
Effective tax rate %-31.724.3 -130.1%   
Net profit margin %2.512.1 20.6%  
BALANCE SHEET DATA
Current assets Rs m6,88468,746 10.0%   
Current liabilities Rs m8,45627,027 31.3%   
Net working cap to sales %-13.045.4 -28.5%  
Current ratio x0.82.5 32.0%  
Inventory Days Days6285 72.5%  
Debtors Days Days10896 112.6%  
Net fixed assets Rs m4,97024,132 20.6%   
Share capital Rs m113282 40.1%   
"Free" reserves Rs m2,87544,643 6.4%   
Net worth Rs m3,02044,925 6.7%   
Long term debt Rs m1,81745,363 4.0%   
Total assets Rs m13,347117,639 11.3%  
Interest coverage x1.67.6 20.4%   
Debt to equity ratio x0.61.0 59.6%  
Sales to assets ratio x0.90.8 116.4%   
Return on assets %5.411.4 47.0%  
Return on equity %10.024.7 40.5%  
Return on capital %13.319.1 69.6%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,84356,152 10.4%   
Fx outflow Rs m2,1738,084 26.9%   
Net fx Rs m3,66948,068 7.6%   
CASH FLOW
From Operations Rs m3986,574 6.0%  
From Investments Rs m-1,635-7,124 23.0%  
From Financial Activity Rs m1,3095,432 24.1%  
Net Cashflow Rs m711,992 3.6%  

Share Holding

Indian Promoters % 39.2 48.3 81.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 6.9 52.2%  
FIIs % 17.6 34.4 51.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 10.5 377.1%  
Shareholders   20,750 56,727 36.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC LTD  SUN PHARMA  PFIZER  FDC LTD.  MERCK LTD  

Compare SHASUN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - BIOCON LTD COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS